Aptamer Group PLC (AIM:APTA)

Market Cap	29.67M
Revenue (ttm)	1.22M
Net Income (ttm)	-2.26M
Shares Out	2.70B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,365,214
Average Volume	43,953,404
Open	1.138
Previous Close	1.100
Day's Range	1.112 - 1.200
52-Week Range	0.200 - 1.570
Beta	0.75
RSI	64.63
Earnings Date	Oct 17, 2025

About Aptamer Group

Aptamer Group PLC, together with its subsidiaries, provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers; and Optimer +, a platform that discovers and develops of hybrid DNA-protein molecules that combines the features of Optimer and antibodies. It serves bioprocessing and diagnostic institutes, as well as pharmaceutical scientists. The company h...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 34
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: APTA

Financial Performance

In 2024, Aptamer Group's revenue was 860,000, a decrease of -50.91% compared to the previous year's 1.75 million. Losses were -2.96 million, -62.25% less than in 2023.